Abstract: The incidence of Hashimoto thyroiditis (HT) combined with papillary thyroid cancer (PTC) is increasing year by year, but the relationship between them remains controversial. This paper reviews the research progress in the epidemiology and pathogenesis, marker antibody, molecular characteristics, clinical pathological features, imaging diagnosis and treatment of HT combined with PTC.